MANKIND Mankind Pharma Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens MANKIND is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about MANKIND
In the last completed session, Mankind Pharma Ltd. closed +0.59% with futures open interest moving -1.9%. That combination — price rising while OI shrinks — is classified as Short Covering. It typically reflects existing short sellers closing positions, not fresh buying. Short-covering rallies can be sharp but tend to fade without follow-through demand. The option PCR of 0.88 is balanced — no clear directional preference from option writers. Max-pain strike at ₹2,500 sits 1.8% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Mankind Pharma Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Mankind Pharma Ltd. points to a supportive setup at the next open.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Broker Calls as reported · last 120 days
| Date | Brokerage | Call | Target | Source |
|---|---|---|---|---|
| 2026-08-02 | InCred | Initiate | — | NDTV Profit |
| 2026-08-01 | InCred | Initiate | — | NDTV Profit |
| 2026-07-30 | InCred | Initiate | — | NDTV Profit |
| 2026-07-29 | InCred | Initiate | — | NDTV Profit |
| 2026-07-28 | InCred | Initiate | — | NDTV Profit |
| 2026-07-27 | InCred | Initiate | — | NDTV Profit |
| 2026-07-26 | InCred | Initiate | — | NDTV Profit |
| 2026-07-25 | InCred | Initiate | — | NDTV Profit |
| 2026-07-24 | InCred | Initiate | — | NDTV Profit |
| 2026-07-23 | InCred | Initiate | — | NDTV Profit |
| 2026-07-22 | InCred | Initiate | — | NDTV Profit |
| 2026-07-21 | InCred | Initiate | — | NDTV Profit |
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-08-25 · spot 2,456 · EOD 2026-08-07
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 35%
Δ 0.76
θ -2.0
ν 2
|
2340 |
IV 31%
Δ -0.21
θ -1.3
ν 2
|
|
IV 16%
Δ 0.90
θ -0.8
ν 1
|
2360 |
IV 30%
Δ -0.25
θ -1.4
ν 2
|
|
IV 27%
Δ 0.73
θ -1.7
ν 2
|
2380 |
IV 30%
Δ -0.28
θ -1.4
ν 2
|
|
IV 25%
Δ 0.70
θ -1.6
ν 2
|
2400 |
IV 29%
Δ -0.33
θ -1.5
ν 2
|
|
IV 24%
Δ 0.64
θ -1.7
ν 2
|
2420 |
IV 29%
Δ -0.38
θ -1.6
ν 2
|
|
IV 25%
Δ 0.58
θ -1.8
ν 2
|
2440 |
IV 29%
Δ -0.43
θ -1.6
ν 2
|
|
IV 25%
Δ 0.52
θ -1.8
ν 2
|
2460 |
IV 29%
Δ -0.48
θ -1.6
ν 2
|
|
IV 25%
Δ 0.46
θ -1.7
ν 2
|
2480 |
IV 27%
Δ -0.54
θ -1.4
ν 2
|
|
IV 26%
Δ 0.41
θ -1.8
ν 2
|
2500 MP |
IV 31%
Δ -0.57
θ -1.6
ν 2
|
|
IV 26%
Δ 0.35
θ -1.7
ν 2
|
2520 |
IV 37%
Δ -0.60
θ -2.0
ν 2
|
|
IV 27%
Δ 0.31
θ -1.6
ν 2
|
2540 |
IV 35%
Δ -0.64
θ -1.8
ν 2
|
|
IV 27%
Δ 0.27
θ -1.5
ν 2
|
2560 |
IV 39%
Δ -0.66
θ -1.9
ν 2
|
|
IV 28%
Δ 0.23
θ -1.4
ν 2
|
2580 |
IV 34%
Δ -0.72
θ -1.5
ν 2
|
Chain Interpretation
Strategy Builder multi-leg payoff for MANKIND options · 2026-08-25 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
MANKIND — frequently asked questions
What is the Mankind Pharma Ltd. share price today?
MANKIND is trading at ₹2,456.00 (+1.48% vs previous close), per the latest update on this page.
What is the P/E ratio of Mankind Pharma Ltd.?
MANKIND (Mankind Pharma Ltd.) has a trailing twelve-month P/E ratio of 49.8.
What is the market cap of Mankind Pharma Ltd.?
MANKIND has a market capitalisation of approximately ₹101,432 crore.
Is MANKIND near its 52-week high?
MANKIND is trading -8.2% from its 52-week high of ₹2,674.00 as of 2026-08-07.
What is the RSI of MANKIND?
The 14-day RSI of MANKIND is 45.2, which is considered neutral.
Is MANKIND above its 200-day moving average?
MANKIND is trading above its 200-DMA of ₹2,277.55 (+7.8% away).
What is the F&O buildup in MANKIND?
The latest end-of-day derivatives data classifies MANKIND as Short Covering (bias: bullish), based on the day's combined price and open-interest change.
What is the max pain and PCR for MANKIND options?
MANKIND's option-chain max pain strike is ₹2,500 and its put-call ratio (OI) is 0.88, from the latest end-of-day option chain.
Are FIIs or big investors buying MANKIND?
Strota tracks every bulk and block deal in MANKIND with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.
What is the latest broker call on MANKIND?
The most recent analyst call reported in the press is InCred: Initiate (2026-08-02). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.